ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Approved

Cerebrolysin

Cerebrolysin

Also known as: FPF-1070, Brain Peptide Complex

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Cerebrolysin

Mimics endogenous neurotrophic factors (BDNF, GDNF, NGF-like activity). Promotes neurogenesis and synaptic plasticity.

Dosing Information

Half-Life

~30 minutes (active metabolites persist longer)

Typical Dose

5–30 mg

Frequency

1x daily for 10-20 day cycles

Cycle Length

10-20 day infusion cycles, repeated as needed

Administration Routes:
intramuscularintravenous

Benefits

  • Promotes neuronal survival and brain plasticity
  • Accelerates recovery after ischemic stroke
  • Improves cognitive function in TBI patients
  • Neurotrophic factor-like activity (mimics BDNF, NGF)
  • May slow cognitive decline in Alzheimer's disease
  • Enhances synaptic density and dendritic branching

Side Effects

Dizzinessmild
Headachemild
Injection site painmild
Nauseamild
Agitation or insomnia (with high doses)mild
Fever (uncommon)mild

Mechanism of Action

1

Mimics endogenous neurotrophic factors (BDNF, GDNF, NGF-like activity)

2

Promotes neurogenesis and synaptic plasticity

3

Inhibits calpain-mediated neuronal death

4

Reduces amyloid-beta aggregation and tau hyperphosphorylation

5

Modulates GSK-3β and CDK5 kinase pathways

Contraindications

Do not use this peptide if any of the following apply:

  • Epilepsy or seizure disorders (may lower threshold)
  • Severe renal insufficiency
  • Pregnancy or breastfeeding
  • Known allergy to porcine-derived products

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Approved

Approved in over 40 countries for stroke, TBI, and dementia. Multiple Phase 3 RCTs including the CASTA trial (stroke) and large Alzheimer's studies. Cochrane reviews note some positive signals but call for additional high-quality trials. Manufactured by EVER Neuro Pharma (Austria).

Frequently Asked Questions

Common questions about Cerebrolysin

UK-Specific Information

Exclusive data points and guidance for UK residents using Cerebrolysin

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok